DRD2 and cocaine use disorder: The current overview supports the hypothesis that the A2AR agonists represent novel drugs against cocaine use disorder because they inter alia can trigger the antagonistic allosteric A2AR-D2R interactions in A2AR-DR2 and A2AR-D2R-sigma-1R heteroreceptor complexes located in the ventral striatum.